HUDSON BAY CAPITAL MANAGEMENT LP – Neurocrine Biosciences, Inc. Transaction History
HUDSON BAY CAPITAL MANAGEMENT LP portfolio value:
$11.15M
portfolio value
HUDSON BAY CAPITAL MANAGEMENT LP quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -38.24% | -65K shares | -5.42M | $106.21 | 105K |
| Q2 2022 | share | Increase | +9.68% | 15K shares | 2.04M | $97.48 | 170K |
| Q1 2022 | share | Increase | +14.81% | 20K shares | 3.03M | $93.75 | 155K |
| Q4 2021 | share | Increase | +68.98% | 55.11K shares | 3.83M | $84.63 | 135K |
| Q3 2021 | share | Increase | +14.13% | 9.88K shares | 850K | $95.91 | 79.88K |
| Q2 2021 | share | Increase | +7.69% | 5K shares | 491K | $97.32 | 70K |
| Q1 2021 | share | Decrease | -7.14% | -5K shares | -389K | $97.25 | 65K |
| Q4 2020 | share | Increase | +133.33% | 40K shares | 3.82M | $95.85 | 70K |
| Q3 2020 | share | Increase | 0.00% | 30K shares | 2.88M | $96.16 | 30K |
| Q2 2020 | share | Decrease | -100.00% | -10K shares | -866K | $122 | 0 |
| Q1 2020 | share | Increase | 0.00% | 10K shares | 866K | $86.55 | 10K |
| Q3 2019 | share | Decrease | -100.00% | -30K shares | -2.53M | $90.11 | 0 |
| Q2 2019 | share | Increase | +500.00% | 25K shares | 2.09M | $84.43 | 30K |
| Q1 2019 | share | Increase | 0.00% | 5K shares | 441K | $88.1 | 5K |